Details for 2012809882

Up to date per 01.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE FORMULIERUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2012809882

EP Publication Number

2782557

E-Number

1039765

Language

PCT Number

US12066185

Publication Date

01.10.2014 A

12.09.2018 B1

Registration Date

12.09.2018

AT Publication Date

15.10.2018

Application Date

21.11.2012

Registration Number

Priorities

23.11.2011

201161563229 P

IPC

A61K 31/506 20060101AFI20180320BHEP

Maximum Duration of Protection

21.11.2032

Owner

Array Biopharma, Inc.3200 Walnut Street Boulder, CO 80301US

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

VERMA, DayaNovartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080US

KRISHNAMACHARI, Yogita62 Astor Place Springfield New Jersey 07081US

SHEN, XiaohongNovartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080US

LEE, HanchenNovartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080US

LI, PingBeijing Novartis Pharma Co., Ltd. No. 72 Liangxiu Road Zhangjang Hi-Tech Park Shanghai, 201203CN

SINGH, RajinderNovartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080US

TAN, LayChooNovartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080US

Information about Fees